Showing results (111-120 of 146) with videos related to

Sort By:
Pageof 15
Frontiers in Immunology|October 28, 2022
Pembrolizumab in Chinese patients with advanced melanoma: 3-year follow-up of the KEYNOTE-151 studyLu Si, Xiaoshi Zhang, Yongqian Shu, et al.
Frontiers in Surgery|January 20, 2022
Surgical Outcomes of Vaginal or Cervical MelanomaHui Tian, Xuan Wang, Bin Lian, et al.
Med (New York, N.Y.)|March 20, 2025
Efficacy and safety of DV in HER2-negative and HER2-low locally advanced or metastatic urothelial carcinoma: Results of a phase 2 studyXieqiao Yan, Juan Li, Huayan Xu, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 25, 2023
Phase Ib study of anlotinib in combination with anti-PD-L1 antibody (TQB2450) in patients with advanced acral melanomaYu Du, Jie Dai, Lili Mao, et al.
The Oncologist|March 27, 2023
HER2 Expression Associated with Clinical Characteristics and Prognosis of Urothelial Carcinoma in a Chinese PopulationLi Zhou, Zhiting Shao, Yiqiang Liu, et al.
European Journal of Cancer (Oxford, England : 1990)|August 23, 2021
Real-world efficacy and safety of axitinib in combination with anti-programmed cell death-1 antibody for advanced mucosal melanomaBixia Tang, Jiazhi Mo, Xieqiao Yan, et al.
Urologic Oncology|February 21, 2024
Natural history of bone-only metastasis in renal cell carcinomaBixia Tang, Rong Duan, Zenan Fan, et al.
Annals of Surgical Oncology|May 12, 2018
Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma PatientsChuanLiang Cui, Bin Lian, Li Zhou, et al.
Translational Oncology|April 14, 2019
A Phase Ib Study of Pembrolizumab as Second-Line Therapy for Chinese Patients With Advanced or Metastatic Melanoma (KEYNOTE-151)Lu Si, Xiaoshi Zhang, Yongqian Shu, et al.
European Journal of Cancer (Oxford, England : 1990)|June 23, 2018
Sorafenib in combination with gemcitabine plus cisplatin chemotherapy in metastatic renal collecting duct carcinoma: A prospective, multicentre, single-arm, phase 2 studyXinan Sheng, Dengfeng Cao, Jianlin Yuan, et al.
Pageof 15